BeSound is coming soon!
Be among the first to experience a revolutionary approach to breast cancer detection. Sign up for our waitlist today to receive exclusive early access.
The FDA has released new legislation requiring providers to screen specificially for dense breasts.
Near-infrared light allows for the visualization of vascular structures and oxygenation of surrounding tissue, revealing malignancies.
*Medical images provided by partner company, Seno Medical
A better, safer, more cost-effective way to detect cancer in women with dense breasts, helping women everywhere lead healthier lives.*
Discovered in the 1800s by Alexander Graham Bell and adapted by our partner company with FDA approval, Photoacoustic imaging (advanced ultrasound) has been around for years.
Similar to a pulse oximeter on your finger.
Another image is constructed from this data.
Based on the latest cutting-edge models.
Before finalizing and sending results to the patient.
*BeSound ultrasound technology is under development and is subject to ongoing testing. BeSound technology has not been authorized by any regulatory authority for commercial sale.
Be among the first to experience a revolutionary approach to breast cancer detection. Sign up for our waitlist today to receive exclusive early access.